.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Soulshine Cannabis is stocked at 96 licensed dispensaries across Washington, with the deepest coverage in Tacoma, Vancouver, Seattle, Everett, and Spokane. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Soulshine Cannabis concentrated 89.32% of sales in Edible, where category sales grew 321.50% year over year and 3.43% month over month, while the brand’s overall average price rose 4.50% YoY to $11.49. Secondary categories retreated: Beverage held 5.99% share with -14.94% YoY and -1.93% MoM, and Pre-Roll at 3.14% share fell -73.73% YoY and -7.07% MoM. Smaller lines contracted sharply—Concentrates at 0.77% share declined -29.67% YoY and -43.44% MoM, Flower at 0.44% share dropped -97.31% YoY and -28.41% MoM, and Vapor Pens at 0.35% share slid -93.53% YoY and -17.17% MoM—while the brand’s Edible rank in Washington sits at 15. The pattern indicates a deliberate pivot to Edible scale with diminished breadth, trading multi-category reach for depth that can support price stability and share concentration.
With Edible now near nine-tenths of mix and Beverage plus Pre-Roll shrinking double digits, the portfolio is optimized for one purchase occasion rather than a cross-category basket, which can lift operational focus but limits resilience if Edible growth normalizes. The 3.43% MoM uptick in Edible versus double‑digit MoM declines in Concentrates (-43.44%) and Vapor Pens (-17.17%) signals that shelf space and promotional weight are likely migrating to Edible, supporting current velocity but raising dependency risk if competitive pressure intensifies at rank 15 in Washington. Net effect: the brand’s positioning skews toward value-accessible Edible (avg price $12.00 vs brand average $11.49) with reduced trial pathways from legacy inhalables, implying that future share gains will hinge on sustaining Edible innovation and targeted price architecture rather than multi-category upsell.
Competitive Landscape
Soulshine Cannabis sits at rank 15 in WA Edible in August 2026, improving 9 positions from rank 24 year over year, after peaking at rank 14 in July 2026 and edging up 1 spot from rank 16 three months ago; this upward drift contrasts with Wyld holding rank 1 with a 5.1% YoY sales increase while Green Revolution remains rank 2 with a 7.0% YoY sales decline, indicating the ladder is tightening at the top as mid-tier mobility opens. The top five show mixed momentum—Hot Sugar is steady at rank 3 despite a 6.3% YoY drop and Craft Elixirs holds rank 5 with a 13.9% YoY decline—suggesting Soulshine Cannabis’s 9-rank YoY climb is more about share reallocation than category expansion, and the thesis is that a continued single-digit rank gain pace would position Soulshine Cannabis to re-enter the low-teens and contest for top-10 as incumbents with negative mid-single to low-double-digit trends create openings.
Notable Products
Moon - CBD/CBN/THC 3:2:1 Blueberry Lemon Gummies 10-Pack (300mg CBD, 200mg CBN, 100mg THC) posted the steepest pullback at -10.6% month over month while holding rank 2, as Moon - CBD/CBN/THC 3:2:1 Blue Raspberry Hash Rosin Gummies 10-Pack (300mg CBD, 200mg CBN, 100mg THC) rose 27.0% to rank 1, indicating a shuffle within the top two rather than a category-level retreat. Sun - CBD/CBG/THC 3:2:1 Pineapple Gummies 10-Pack (300mg CBD, 200mg CBG, 100mg THC) climbed 17.4% to rank 9 as Sun - CBD/CBG/THC 3:2:1 Pink Lemonade Hash Rosin Gummies 10-Pack (300mg CBD, 200mg CBG, 100mg THC) slipped -11.8% at rank 10, showing volatility at the lower end of the leaderboard. Eight of the top ten are Edibles under the Moon or Sun 3:2:1 mixed-cannabinoid gummies family, concentrating revenue into a few balanced-ratio formats and implying Soulshine Cannabis is consolidating around functional gummy lines rather than diversifying into new form factors.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
